HKD 7.2
(-0.69%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 796.54 Million CNY | 12.87% |
2022 | 705.69 Million CNY | -8.61% |
2021 | 772.18 Million CNY | 70.24% |
2020 | 453.57 Million CNY | 71.97% |
2019 | 263.74 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 832.06 Million CNY | 0.0% |
2024 Q1 | 832.06 Million CNY | 4.46% |
2023 Q4 | 796.54 Million CNY | 0.0% |
2023 FY | 796.54 Million CNY | 12.87% |
2023 Q1 | 735.17 Million CNY | 4.18% |
2023 Q3 | 796.54 Million CNY | 8.35% |
2023 Q2 | 735.17 Million CNY | 0.0% |
2022 Q3 | 705.69 Million CNY | -5.58% |
2022 Q1 | 747.37 Million CNY | -3.21% |
2022 FY | 705.69 Million CNY | -8.61% |
2022 Q4 | 705.69 Million CNY | 0.0% |
2022 Q2 | 747.37 Million CNY | 0.0% |
2021 Q3 | 772.18 Million CNY | 0.0% |
2021 Q4 | 772.18 Million CNY | 0.0% |
2021 Q1 | - CNY | 0.0% |
2021 FY | 772.18 Million CNY | 70.24% |
2020 FY | 453.57 Million CNY | 71.97% |
2019 FY | 263.74 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Life Healthcare Group Limited | 336.13 Million HKD | -136.972% |
China Biotech Services Holdings Limited | 662.36 Million HKD | -20.258% |